Sinovac Biotech Ltd
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q2 13 | Q3 13 | Q4 13 | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | 166.1 | 99.2 | 614.8 | – | – | – | 210.9 | – | – | 930.4 | – | – | – | 92.5 | 16.2 | 16.1 | 12.7 | 12.8 | 13.4 | 14.3 | 21.5 | 26.9 | 28.0 | 25.4 | 44.9 | 96.2 | – | – | 4.2 | 2.6 | 0.1 | 0.1 | – | – | – | 16.1 | – | |
| 3.8 | 3.5 | 4.8 | 5.4 | 6.1 | 5.1 | 4.8 | 4.6 | 4.8 | 4.6 | 4.4 | 5.9 | 6.4 | 8.4 | 6.5 | 4.6 | 3.4 | 2.4 | 2.5 | 1.9 | 2.0 | 1.7 | 1.9 | 2.7 | 2.7 | 3.9 | 3.2 | 3.6 | 4.0 | 4.4 | 3.7 | 1.4 | 0.9 | 0.1 | 0.0 | – | – | – | 0.2 | – | |
| 1.8 | 1.8 | 2.6 | 2.7 | 3.2 | 2.5 | 2.1 | 2.3 | 2.3 | 2.3 | 2.3 | 2.6 | 3.0 | 3.0 | 2.9 | 2.9 | 2.5 | 3.0 | 3.5 | 3.0 | 3.3 | 2.7 | 2.1 | 2.2 | 2.1 | 2.8 | 2.4 | 2.3 | 2.3 | 2.3 | 2.4 | 1.0 | 1.0 | 0.1 | 0.1 | 0.1 | 0.1 | – | 0.1 | 0.1 | |
| 3.0 | 2.8 | 4.1 | 4.9 | 5.3 | 4.5 | 4.2 | 4.0 | 4.3 | 4.1 | 4.0 | 5.3 | 5.9 | 7.9 | 6.1 | 4.4 | 3.2 | 2.3 | 2.4 | 1.6 | 1.7 | 1.5 | 1.4 | 2.1 | 2.0 | 3.1 | 2.5 | 2.8 | 3.1 | 3.7 | 3.3 | -0.5 | -0.3 | -0.5 | -0.5 | – | – | – | -0.2 | – | |
| – | – | 48.7 | 22.0 | 19.5 | 20.0 | 22.2 | 20.8 | 31.6 | 18.6 | 20.6 | 41.2 | 46.3 | – | – | 77.4 | – | – | – | – | 5.4 | 4.9 | 4.7 | 7.7 | 8.6 | 11.1 | 9.7 | 13.1 | 20.7 | 180.8 | 44.0 | -1.1 | -0.6 | -0.6 | -0.6 | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13.4 | 13.8 | 11.3 | – | – | – | – | – | – | – | – | 2.1 | 0.9 | 0.1 | 0.0 | – | – | – | – | – | |
| -12.4% | -8.8% | -4.4% | -7.5% | -6.4% | -10.0% | -11.7% | -6.8% | -7.7% | -4.4% | -3.5% | -8.3% | -8.3% | -10.9% | -10.9% | -8.4% | – | – | – | – | 7.4% | 7.2% | 8.9% | -2.4% | -3.1% | -0.4% | -0.8% | -2.7% | -4.6% | -10.0% | -12.6% | 47.6% | 107.8% | 1,277.9% | 2,084.8% | – | – | – | -233.5% | – | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 62.8% | 63.6% | 66.7% | 72.1% | 73.1% | 72.2% | 74.1% | 73.9% | 73.6% | 75.8% | 74.8% | 71.5% | 68.4% | 53.7% | 64.1% | 69.1% | 77.2% | 84.0% | 82.7% | 86.4% | 87.6% | 86.9% | 89.3% | 89.8% | 88.7% | 90.4% | 88.1% | 87.7% | 87.2% | 85.2% | 87.1% | 86.8% | 86.8% | 93.8% | 94.2% | – | – | – | 34.3% | – | |
| -30.2% | -17.4% | -4.5% | 7.1% | 11.0% | 3.6% | 0.2% | 0.8% | -3.6% | 7.8% | 4.4% | -0.5% | 0.0% | -45.1% | -20.6% | 0.7% | 9.3% | 22.3% | 24.3% | 25.9% | 27.8% | 27.1% | 27.2% | 23.5% | 19.8% | 24.7% | 22.2% | 17.2% | 10.8% | -2.8% | 5.0% | 42.2% | 51.2% | 89.8% | 89.6% | – | – | – | -33.0% | – | |
| -22.4% | -14.6% | -5.3% | 3.3% | 6.1% | 0.8% | -3.0% | -1.3% | -5.3% | 2.2% | -0.4% | -5.7% | 0.7% | -28.6% | -12.8% | -0.8% | 3.7% | 14.9% | 15.4% | 14.9% | 15.3% | 12.8% | 13.4% | 12.5% | 9.9% | 13.8% | 12.6% | 7.9% | 4.2% | -6.3% | -3.0% | 34.1% | 35.1% | 46.0% | 43.7% | – | – | – | 1.4% | – | |
| -47.5% | -31.2% | -21.3% | -40.7% | -39.0% | -51.0% | -55.9% | -31.2% | -36.9% | -20.3% | -15.7% | -48.9% | -52.8% | -91.5% | -70.7% | -38.8% | – | – | – | – | 14.6% | 12.4% | 16.9% | -6.4% | -8.1% | -1.7% | -2.7% | -9.6% | -18.4% | -43.6% | -46.7% | 68.9% | 96.8% | 80.6% | 77.1% | – | – | – | -52.3% | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -10.3% | -7.6% | -2.9% | 1.6% | 3.2% | 0.4% | -1.4% | -0.7% | -2.5% | 1.1% | -0.2% | -2.6% | 0.3% | -10.2% | -5.8% | -0.5% | 2.7% | 18.4% | 21.7% | 23.6% | 25.5% | 20.5% | 15.0% | 10.2% | 7.7% | 9.9% | 9.5% | 5.1% | 2.4% | -3.3% | -1.9% | 23.3% | 38.7% | 92.0% | 93.8% | – | – | – | 0.5% | – | |
| -5.5% | -4.0% | -1.5% | 0.9% | 1.7% | 0.2% | -0.7% | -0.4% | -1.5% | 0.6% | -0.1% | -1.5% | 0.2% | -6.3% | -3.3% | -0.3% | 1.4% | 9.8% | 11.9% | 11.9% | 12.9% | 10.9% | 10.2% | 7.0% | 5.2% | 6.5% | 6.2% | 3.3% | 1.5% | -1.7% | -0.9% | 9.2% | 15.2% | 42.8% | 52.2% | – | – | – | 0.3% | – | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -46 | -43 | -51 | -33 | -48 | -39 | -35 | -40 | -30 | -30 | -26 | -29 | -27 | -20 | -17 | -19 | -18 | -18 | -6.9 | -81 | -77 | -63 | -144 | -133 | -135 | -138 | -144 | -145 | -145 | -103 | -90 | -990 | -998 | -6,779 | -11,594 | -6,850 | -4,267 | – | -1,421 | -1,010 | |
| – | – | -8.8 | -2.4 | -2.6 | -2.8 | -3.4 | -3.3 | -3.8 | -2.1 | -2.1 | -4.0 | -3.6 | – | – | -4.7 | – | – | – | – | -1.0 | -0.8 | -1.7 | -2.3 | -2.9 | -2.5 | -2.8 | -3.8 | -6.0 | -34.6 | -6.1 | -4.5 | -2.3 | -0.6 | -0.6 | – | – | – | – | – | |
| 53.8% | 53.4% | 53.5% | 53.3% | 53.3% | 54.1% | 51.9% | 53.1% | 58.7% | 58.5% | 60.5% | 60.4% | 60.4% | 61.6% | 56.4% | 54.8% | 53.1% | 53.1% | 54.8% | 50.5% | 50.5% | 53.1% | 68.5% | 67.9% | 67.9% | 66.0% | 64.9% | 65.5% | 65.5% | 52.8% | 46.5% | 39.3% | 39.3% | 46.5% | 55.7% | 62.8% | 63.2% | – | 63.1% | 63.8% | |
| 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.5 | 0.4 | 0.3 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | 0.5 | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.22 | -0.16 | -0.07 | 0.04 | 0.07 | 0.01 | -0.03 | -0.02 | -0.06 | 0.03 | 0.00 | -0.06 | 0.01 | -0.20 | -0.12 | -0.01 | 0.06 | 0.42 | 0.44 | 0.62 | 0.67 | 0.56 | 0.53 | 0.32 | 0.24 | 0.23 | 0.26 | 0.14 | 0.07 | -0.09 | -0.05 | 1.53 | 2.54 | 47.37 | 76.75 | – | – | – | 0.40 | – | |
| 0.97 | 1.11 | 1.24 | 1.13 | 1.19 | 1.10 | 1.00 | 1.12 | 1.05 | 1.16 | 1.15 | 0.97 | 1.00 | 0.70 | 0.91 | 1.27 | 1.66 | 2.81 | 2.86 | 4.18 | 4.39 | 4.38 | 3.98 | 2.57 | 2.44 | 1.68 | 2.03 | 1.82 | 1.61 | 1.49 | 1.75 | 4.49 | 7.24 | 103.07 | 175.71 | – | – | – | 29.02 | – | |
| 2.11 | 2.14 | 2.30 | 2.27 | 2.27 | 2.24 | 2.24 | 2.26 | 2.22 | 2.27 | 2.19 | 2.17 | 2.17 | 1.96 | 2.02 | 2.03 | 2.28 | 2.28 | 2.03 | 2.64 | 2.62 | 2.74 | 3.55 | 3.13 | 3.13 | 2.34 | 2.69 | 2.87 | 2.87 | 2.83 | 2.69 | 6.57 | 6.57 | 51.51 | 81.82 | 82.93 | 89.66 | – | 75.86 | 87.44 | |
| -0.46 | -0.34 | -0.26 | -0.46 | -0.46 | -0.56 | -0.56 | -0.35 | -0.39 | -0.24 | -0.18 | -0.48 | -0.53 | -0.64 | -0.65 | -0.49 | – | – | – | – | 0.64 | 0.54 | 0.67 | -0.17 | -0.20 | -0.03 | -0.05 | -0.18 | -0.30 | -0.65 | -0.82 | 3.09 | 7.00 | 83.06 | 135.51 | – | – | – | -15.18 | – | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.